USE OF AN ANTIBODY AGAINST THE SOLUBLE INTERLEUKIN 2 RECEPTOR α SUBUNIT CAN MODULATE THE STABILITY AND BIODISTRIBUTION OF INTERLEUKIN-2

Hisataka Kobayashi(National Cancer Institute), Jorge A. Carrasquillo(National Institutes of Health), In‐Sook Kim(Frederick National Laboratory for Cancer Research), C H Paik(Cardinal Glennon Children’s Medical Center), Nhat Le(Cardinal Glennon Children’s Medical Center), David L. Nelson(National Institutes of Health), Ira Pastan(National Cancer Institute), Eui‐Sik Han(Cardinal Glennon Children’s Medical Center), T. A. Waldmann(National Cancer Institute), Yutaka Tagaya(University of Maryland, Baltimore)
Cytokine
December 1, 1999
Cited by 18


Related Papers